SE447263B - Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid - Google Patents

Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid

Info

Publication number
SE447263B
SE447263B SE8002726A SE8002726A SE447263B SE 447263 B SE447263 B SE 447263B SE 8002726 A SE8002726 A SE 8002726A SE 8002726 A SE8002726 A SE 8002726A SE 447263 B SE447263 B SE 447263B
Authority
SE
Sweden
Prior art keywords
ala
leu
polypeptide
arg
glu
Prior art date
Application number
SE8002726A
Other languages
English (en)
Swedish (sv)
Other versions
SE8002726L (sv
Inventor
B Luning
Original Assignee
Bonnierfoeretagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonnierfoeretagen Ab filed Critical Bonnierfoeretagen Ab
Publication of SE8002726L publication Critical patent/SE8002726L/
Publication of SE447263B publication Critical patent/SE447263B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hospice & Palliative Care (AREA)
SE8002726A 1979-04-20 1980-04-10 Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid SE447263B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7903505 1979-04-20

Publications (2)

Publication Number Publication Date
SE8002726L SE8002726L (sv) 1980-10-21
SE447263B true SE447263B (sv) 1986-11-03

Family

ID=20337858

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002726A SE447263B (sv) 1979-04-20 1980-04-10 Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid

Country Status (9)

Country Link
US (1) US4327075A (fa)
JP (2) JPS55141452A (fa)
CA (1) CA1157465A (fa)
CH (1) CH645880A5 (fa)
DE (1) DE3014582A1 (fa)
FR (1) FR2454436A1 (fa)
GB (1) GB2047713B (fa)
IT (1) IT1141277B (fa)
SE (1) SE447263B (fa)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ZA814637B (en) * 1980-07-17 1982-08-25 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
US4859765A (en) * 1983-10-17 1989-08-22 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
JPH02504395A (ja) * 1988-03-29 1990-12-13 スクリップス　クリニック　アンド　リサーチ　ファウンデーション アポａｉ定量のための診断方法及び診断システム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485810A (en) * 1967-07-24 1969-12-23 Lilly Co Eli Novel amino acid protecting groups
US4028315A (en) * 1970-10-16 1977-06-07 E. R. Squibb & Sons, Inc. Solid phase synthesis of peptides
US3912711A (en) * 1972-07-03 1975-10-14 Susan E Leeman Synthetically produced undecapeptide, Substance P
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
US3915949A (en) * 1974-02-12 1975-10-28 Armour Pharma Solid phase synthesis of ACTH
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
US4062746A (en) * 1975-05-07 1977-12-13 Wisconsin Alumni Research Foundation Solid phase synthesis of protected peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4031070A (en) * 1976-03-01 1977-06-21 Parke, Davis & Company Tetrapeptides
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization

Also Published As

Publication number Publication date
GB2047713B (en) 1983-02-02
DE3014582A1 (de) 1980-10-30
DE3014582C2 (fa) 1990-11-08
JPH0240986B2 (fa) 1990-09-14
SE8002726L (sv) 1980-10-21
FR2454436B1 (fa) 1983-06-10
US4327075A (en) 1982-04-27
IT8021411A0 (it) 1980-04-16
CH645880A5 (de) 1984-10-31
CA1157465A (en) 1983-11-22
JPS55141452A (en) 1980-11-05
FR2454436A1 (fr) 1980-11-14
JPS6364440B2 (fa) 1988-12-12
JPH01173871A (ja) 1989-07-10
GB2047713A (en) 1980-12-03
IT1141277B (it) 1986-10-01

Similar Documents

Publication Publication Date Title
US5783674A (en) Method for the use and synthesis of peptides
US4833166A (en) Growth hormone releasing hormone complementary peptides
US4107298A (en) Antigenically active polypeptide and a process for its preparation
JP2003521448A (ja) 合成ペプチドおよび自己免疫疾患治療のための使用方法
SE447263B (sv) Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
US10597426B2 (en) Polypeptide compound and preparation method and use thereof
Nakashima et al. Primary structure of the major coat protein of the filamentous bacterial viruses, If1 and Ike.
JPH10511078A (ja) 免疫刺激剤
NO149998B (no) Analogifremgangsmaate til fremstilling av peptider med ubiquitinlignende aktivitet
US20050256056A1 (en) Peptide inhibitors of HIV
US20180244724A1 (en) Polypeptide compound and preparation method and use thereof
Braun et al. Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N‐terminal β‐globin chain peptides
EP0138616A2 (en) Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them
JPH111493A (ja) ペプチドおよびこれを固定化してなる医療材料
DK149093B (da) Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf
JP2001192399A (ja) ｇｐ１２０に親和性を有するペプチド
SE446867B (sv) Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
RU2145233C1 (ru) Неупорядоченная библиотека пептидов, способ ее получения и способ идентификации пептида, синтезированного твердофазным синтезом
CA2234723A1 (en) Generating d-peptides: methods and compositions
JPH10182696A (ja) ｇｐ１２０に対して親和性を有するペプチド
JP3391831B2 (ja) 環状ペプチド
JPH10182695A (ja) ｇｐ１２０に対して親和性を有するペプチド
JP2002053596A (ja) アポトーシス誘導ペプチド、そのスクリーニング方法およびアポトーシス誘導剤
EP0535804A1 (en) Peptide compounds
Birr et al. Molecular perspectives of synthetic mast cell-degranulating peptide

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8002726-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8002726-1

Format of ref document f/p: F